Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NALOXONE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Naloxone Hydrochloride

Subscribe to access the full database, or try a Free Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000192	Neurobiology of Opioid Dependence: 1 - 1	Withdrawn	National Institute on Drug Abuse (NIDA)	Phase 2	The purpose of this study is to evaluate the effects of lamotrigine on naloxone-precipitated opiate withdrawal.
NCT00000192	Neurobiology of Opioid Dependence: 1 - 1	Withdrawn	Yale University	Phase 2	The purpose of this study is to evaluate the effects of lamotrigine on naloxone-precipitated opiate withdrawal.
NCT00000193	Neurobiology of Opioid Dependence: 2 - 2	Withdrawn	National Institute on Drug Abuse (NIDA)	Phase 2	The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.
NCT00000193	Neurobiology of Opioid Dependence: 2 - 2	Withdrawn	Yale University	Phase 2	The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.
NCT00000194	Neurobiology of Opioid Dependence: 3 - 3	Withdrawn	National Institute on Drug Abuse (NIDA)	Phase 2	The purpose of this study is to study the effects of cycloserine on naloxone-precipitated opiate withdrawal.
NCT00000194	Neurobiology of Opioid Dependence: 3 - 3	Withdrawn	Yale University	Phase 2	The purpose of this study is to study the effects of cycloserine on naloxone-precipitated opiate withdrawal.
Trial ID	Title	Status	Sponsor	Phase	Summary

Clinical Trial Conditions for Naloxone Hydrochloride

Condition Name

Chart
Table

Condition Name for Naloxone Hydrochloride
Intervention	Trials
Opioid-Related Disorders	37
Pain	24
Opioid Dependence	16
Heroin Dependence	14
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Chart
Table

Condition MeSH for Naloxone Hydrochloride
Intervention	Trials
Opioid-Related Disorders	59
Constipation	17
Drug Overdose	15
Heroin Dependence	15
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Naloxone Hydrochloride

Trials by Country

Map
Table

Trials by Country for Naloxone Hydrochloride
Location	Trials
United States	353
China	21
Canada	17
Norway	13
Germany	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Map
Table

Trials by US State for Naloxone Hydrochloride
Location	Trials
New York	34
California	25
Maryland	24
Texas	16
Florida	15
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Naloxone Hydrochloride

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Naloxone Hydrochloride
Clinical Trial Phase	Trials
Phase 4	58
Phase 3	47
Phase 2/Phase 3	7
[disabled in preview]	101
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Chart
Table

Clinical Trial Status for Naloxone Hydrochloride
Clinical Trial Phase	Trials
Completed	142
Recruiting	38
Not yet recruiting	28
[disabled in preview]	41
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Naloxone Hydrochloride

Sponsor Name

Chart
Table

Sponsor Name for Naloxone Hydrochloride
Sponsor	Trials
National Institute on Drug Abuse (NIDA)	49
Indivior Inc.	12
Mundipharma Research GmbH & Co KG	12
[disabled in preview]	22
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Chart
Table

Sponsor Type for Naloxone Hydrochloride
Sponsor	Trials
Other	213
Industry	93
NIH	58
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.